Trailing-twelve-month (TTM) revenue is $2.98 Billion with a year-over-year growth of +5.17%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $757,836,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-27 |
| Q4 FY2025Period ended 2026-01-03 | $925,451,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-04-04 | $681,113,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-07-04 | $615,490,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $2,979,890,000 |
Current P/S: $1,181,782,707 market capitalization ÷ $2,979,890,000 TTM revenue = 0.40x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:02.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $615.49M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| Baby | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B | $1.3B |
| Other Products | $504M | $599M | $492M | $443M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| International | $357M | $461M | $452M | $429M | $406M | $431M |
| Retail | N/A | N/A | N/A |
$2.98B
$2.98 Billion
+5.17%
vs. $2.83B a year ago (TTM)
(2.54%)
5 Year compound annual growth rate
1 Year
+5.17%
3 Year
(0.52%)
5 Year
(2.54%)
10 Year
(0.33%)
15 Year
+3.13%
20 Year
+4.25%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.90B | +$54.32M | +1.91% |
| 2024 | $2.84B | ($101.49M) | (3.45%) |
| 2023 | $2.95B | ($267.14M) | (8.32%) |
| 2022 | $3.21B | ($273.71M) | (7.85%) |
| 2021 | $3.49B | +$462.11M | +15.28% |
| 2020 |
TTM Growth
+5.17%
3-Year CAGR
(0.52%)
5-Year CAGR
(2.54%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $383M |
| $372M |
| Playclothes | $1.1B | $1.3B | $1.1B | $993M | $949M | $915M |
|---|
| Sleepwear | $441M | $501M | $492M | $412M | $373M | $352M |
|---|
| N/A |
| $1.5B |
| US Retail | $1.7B | $1.9B | $1.7B | $1.5B | $1.4B | N/A |
|---|
| US Wholesale | $996M | $1.1B | $1.1B | $1.0B | $1.0B | N/A |
|---|
| Wholesale | N/A | N/A | N/A | N/A | N/A | $1.0B |
|---|
| $3.02B |
| ($494.95M) |
| (14.06%) |
| 2019 | $3.52B | +$57.02M | +1.65% |
| 2018 | $3.46B | +$61.86M | +1.82% |
| 2017 | $3.40B | +$201.23M | +6.29% |
| 2016 | $3.20B | +$185.31M | +6.15% |
